Cargando…
Long-Term Survival in Patients Receiving Combination Therapy with Resection and Radiofrequency Ablation for Multi-Focal Hepatocellular Carcinoma Classified as Barcelona Clinic Liver Cancer Stage B: A Retrospective Controlled Study
OBJECTIVE: To evaluate the survival outcomes of combined liver resection (LR) and radiofrequency ablation (RFA) on multi-focal hepatocellular carcinoma (HCC) in patients with Barcelona clinic liver cancer (BCLC) stage B. METHODS: A total of 210 cases of HCC were included in this study. In 42 cases,...
Autores principales: | Yan, Jun, Man, Zhongsong, Lu, Qian, Ma, Kuansheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173838/ https://www.ncbi.nlm.nih.gov/pubmed/32368139 http://dx.doi.org/10.2147/CMAR.S237635 |
Ejemplares similares
-
Radiofrequency ablation versus resection for Barcelona clinic liver cancer very early/early stage hepatocellular carcinoma: a systematic review
por: He, Zhen-Xin, et al.
Publicado: (2016) -
Radiofrequency ablation versus hepatic resection for the treatment of early-stage hepatocellular carcinoma meeting Milan criteria: a systematic review and meta-analysis
por: Duan, Chenyang, et al.
Publicado: (2013) -
Efficacy of re-resection versus radiofrequency ablation for recurrent Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma (HCC) after resection for primary HCC
por: Yin, Xieling, et al.
Publicado: (2019) -
Evaluation of Ghost Cell Survival in the Area of Radiofrequency Ablation
por: Wang, Qi, et al.
Publicado: (2012) -
Transarterial chemoembolization as a substitute to radiofrequency ablation for treating Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma
por: Ishikawa, Kentaro, et al.
Publicado: (2018)